CAN
CLVS

Cetera Advisor Networks’s Clovis Oncology, Inc. CLVS Stock Holding History

Cetera Advisor Networks’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,400
Closed -$23K – 3239
2020
Q2 		$23K Buy
+3,400
New +$25.7K ﹤0.01% 2331

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cetera Advisor Networks's CLVS Position: Q3 2020 in Review

Cetera Advisor Networks sold out of Clovis Oncology, Inc. (CLVS) in Q3 2020, closing a stake of 3,400 shares — an estimated $23K sold.

Cetera Advisor Networks first reported a position in CLVS in Q2 2020 and held it in 1 quarter. The position peaked at $23K in Q2 2020. 169 funds tracked by Wall St. Rank hold CLVS as of Q3 2020.

  • Cetera Advisor Networks reported no remaining Clovis Oncology, Inc. position as of Q3 2020 after selling out during the quarter.
  • Cetera Advisor Networks sold 3,400 Clovis Oncology, Inc. shares in Q3 2020, an estimated $23K.
  • Cetera Advisor Networks first reported a position in Clovis Oncology, Inc. in Q2 2020 and held it in 1 quarter.
  • Cetera Advisor Networks's Clovis Oncology, Inc. position peaked at $23K in Q2 2020.
  • 169 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2020.

Based on Cetera Advisor Networks's 13F filing for Q3 2020, filed 13 Nov 2020.